Now Offering Moderna, JJ, Pfizer Bivalent Vaccines for Adults & Kids 5 and Older
    
        
    
     
    
    
    
    
    
        
         
                
            
                
                    
                        
                        
                            
                            
                                
                                                                    
                                
                                    
                                    Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis
                                    Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.
                                 
                                                     
                            
                            
                                                        
                                 
                                Health News is provided as a service to Pacific Medical Pharmacy #1 site users by HealthDay. Pacific Medical Pharmacy #1 nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
                                Copyright © 2025 HealthDay All Rights Reserved.